4 Risk Management in Pharmaceutical and Medical Device Regulation on Government Level(Risk Management in Cardiovascular Practice,Symposium 21 (SY-21) (H),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)

スポンサーリンク

概要

• 論文の詳細を見る
• 社団法人日本循環器学会の論文
• 2009-03-01

著者

• Ono Shunsuke

  Graduate School Of Pharmaceutical Sciences The University Of Tokyo

関連論文

• Characteristics of Clinical Trials Conducted in Japan under the New GCP Guideline : Analysis of PMDA Audit Reports
• 3 Regulatory Perspective on Global Development of New Drugs(Clinical Trials in Global Era,Roundtable Discussion 2 (RT-2) (H),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
• 4 Risk Management in Pharmaceutical and Medical Device Regulation on Government Level(Risk Management in Cardiovascular Practice,Symposium 21 (SY-21) (H),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)

スポンサーリンク